Scholars Central

ArticlePublished 30 Sep 2025

Metabolic outcomes in samples of PCOS reproductive aged Iraqi women reversed by oral combined metformin and spironolactone treatment

Authors: Mustafa Mohammed Albassam, Yasser Kadhim Hashem Al-Zwaini, Alaa Al-Noori, Mohammed Hasan Kadhim, Hilal Abdulla Younis

Ginekologia i Poloznictwo

Volume 20 · Issue 3 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: One of the most critical parameters to diagnose Polycystic Ovarian Syndrome (PCOS) is prolactin (Pr), Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH) and Luteinizing Hormone/Follicle- Stimulating Hormone (LH/FSH) ratio. Objective: Assess the clinical metabolic outcomes value of LH/FSH ratio, LH, FSH and Pr in productive-age women having polycystic ovarian syndrome after an average treatment period of three months with combined Metformin and Spironolactone. Design: A retrospective pilot study. Setting: Private Gynaecological Clinics, Baghdad, Iraq. Patients and methods: We selected reproductive-aged women with PCOS who underwent enzyme-linked immunosorbent assay tests of FSH, LH, and Pr before and after treatment. Women with hyperprolactinemia, thyroid disease, Cushing’s syndrome, and adrenal hyperplasia were excluded. We investigated patients, Pre-treatment and Post-treatment regarding Metformin (MET) 500 mg q.i.d/day and Spironolactone (SPR) 50 mg/day treatment. Main outcome measure: LH/FSH ratio, LH, FSH, Pr, menstrual cycle, hirsutism and acne. Sample size: Thirty. Results: LH and Pr showed a highly significant decreased after combined treatment with MET and SPR when compared with Pretreatment (P=.0001, .0004), respectively, Menstrual Cycle/Year showed a significant increase in Post-treatment (P=.0001) and no significant change in body mass index and FSH parameter when compared Posttreatment with Pre-treatment (P=.297, .296) respectively, and a highly significant decreased and improvement in hirsutism and acne symptoms in Post-treatment when compared with Pre-treatment (P=.0001, .0073) respectively. Conclusion: LH, LH/FSH ratio, Pr, menstrual irregularity, hirsutism, and acne as metabolic outcomes of PCOS can be reversed to normal by using combined MET and SPR as a complementary effect for three months.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Ginekologia i Poloznictwo.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalGinekologia i Poloznictwo
  • SubjectReproductive Medicine & Gynaecology
  • BylineArticles whose byline prints “Mustafa Mohammed Albassam”
  • BylineArticles whose byline prints “Yasser Kadhim Hashem Al-Zwaini”
  • BylineArticles whose byline prints “Alaa Al-Noori”
  • BylineArticles whose byline prints “Mohammed Hasan Kadhim”
  • BylineArticles whose byline prints “Hilal Abdulla Younis”